Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Early Reperfusion With Adjuvant Dornase Alfa in Large Vessel Ischemic Stroke (EXTEND-IA DNase)

NCT05203224 is registered in ClinicalTrials.gov with University of Melbourne as lead sponsor.

NCT NCT05203224
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05203224 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Early Reperfusion With Adjuvant Dornase Alfa in Large Vessel Ischemic Stroke (EXTEND-IA DNase)
Lead sponsor
University of Melbourne
Phase
Phase 2
Overall status
Completed
Start date
February 18, 2022
Completion date
February 25, 2026
Enrollment
330 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke